ljc 10627 has been researched along with linezolid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Bell, DT; Culhane, JC; Ebner, DC; Heuer, AM; Ippoliti, JT; Kaushik, A; Lamichhane, G; Parrish, N | 1 |
Castagnolo, D; Denny, WA; Dos Santos, JL; Fernandes, GFS; Thompson, AM | 1 |
Belz, DC; Deck, DH; Ignatius, EH; Lamichhane, G; Lippincott, CK; Nicklas, DA; Panthi, CM; Rimal, B; Serio, AW | 1 |
1 review(s) available for ljc 10627 and linezolid
Article | Year |
---|---|
Tuberculosis Drug Discovery: Challenges and New Horizons.
Topics: Antitubercular Agents; COVID-19 Drug Treatment; Drug Discovery; Humans; Mycobacterium tuberculosis; Tuberculosis | 2022 |
4 other study(ies) available for ljc 10627 and linezolid
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Structure-Activity Relationship | 2016 |
Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease.
Topics: Animals; Anti-Bacterial Agents; Cefoxitin; Cystic Fibrosis; Imipenem; Linezolid; Mice; Microbial Sensitivity Tests; Mycobacterium abscessus; Rifabutin; Tetracyclines | 2023 |